PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma (British Journal of Cancer, 2012)

(untitled) - Brault, L; Menter, T; Obermann, E; Knapp, S; Thommen, S; Schwaller, J; Tzankov, A